Categories: aggregated

If The FDA Approves It, 5 Million Depressed Americans Could Benefit From a New Psychedelic Therapy

Researchers at the Centre for Psychedelic Research at Imperial College in London found that taking magic mushrooms were more successful at treating depression compared to the widely prescribed SSRI antidepressants. For the study, they focused on escitalopram, an SSRI antidepressant, and psilocybin.

Jason

Share
Published by
Jason

Recent Posts

Housing Crisis, Fentanyl, and Dogs With ODs: The Hidden Toll of Skid Row’s Opioid Epidemic

Animal rescuers and advocacy groups say dogs living on Skid Row are suffering from neglect,…

21 hours ago

Cannabis Doesn’t Distort Reality. It Shows You the Director’s Cut.

This article originally appeared in High Times’ 50th Anniversary print issue. It is an excerpt…

2 days ago

Regulated, Untamed, and Built to Last: Inside Montana Cannabis

How Montana built a legal cannabis market from a thin medical marijuana law, federal raids,…

3 days ago

How to Make a Medical Cannabis Study Say Whatever You Need It To Say

Start reading studies like a journalist rather than a supplicant. Find out who funded them,…

4 days ago

Why Serious Growers Stay Loyal to Hypno Seeds

Most cannabis genetics are known for one standout trait: yield, potency, or terpene expression. Hypno…

5 days ago

The Trump DOJ Said Weed Smokers Were Too Dangerous To Own Guns. All 9 Supreme Court Justices Disagreed.

A unanimous Supreme Court ruled the government can’t strip your gun rights just because you…

5 days ago